Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $39.5350 (3.22%) ($39.5350 - $39.5350) on Fri. Aug. 20, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.93% (three month average) | RSI | 44 | Latest Price | $39.5350(3.22%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.9% a day on average for past five trading days. | Weekly Trend | HALO declines -0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(51%) IWO(50%) IWM(48%) IWC(45%) IWN(45%) | Factors Impacting HALO price | HALO will decline at least -0.965% in a week (0% probabilities). VIXM(-29%) VXX(-11%) UUP(-11%) GLD(-2%) TBT(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.965% (StdDev 1.93%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $35.83(-9.37%) | Resistance Level | $40.66 | 5 Day Moving Average | $39.85(-0.79%) | 10 Day Moving Average | $40.41(-2.17%) | 20 Day Moving Average | $40.66(-2.77%) | To recent high | -14.8% | To recent low | 3.2% | Market Cap | $5.403b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |